Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan

Other Plans and Options
  • (-0.93%)Nav, as on 09-01-2026

  • Previous Nav

  • Net Change on 09-01-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth 1.42 0.18 -0.73 23.17 14.38 20.79
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth Jul 10, 2019 -0.73 23.17 14.38 1.02 837.41
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 -1.25 22.75 15.31 0.91 8,264.71
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 0.78 27.92 17.77 1.02 6,455.55
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 -2.70 24.68 16.84 0.91 3,989.42
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 -4.59 22.92 16.34 0.56 3,114.33
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 0.05 23.47 16.32 0.47 2,770.84

Fund Holdings as on 31-December-2025

  • Sun Pharmaceutical Industries Limited

  • Apollo Hospitals Enterprise Limited

  • Cipla Limited

  • Torrent Pharmaceuticals Limited

  • J.B. Chemicals & Pharmaceuticals Limited

  • Abbott India Limited

  • Ajanta Pharmaceuticals Limited

  • Aurobindo Pharma Limited

  • Fortis Healthcare Limited

  • Lupin Limited

  • IPCA Laboratories Limited

  • Emcure Pharmaceuticals Ltd

  • Mankind Pharma Ltd

  • Alkem Laboratories Limited

  • Jupiter Life Line Hospitals Ltd

  • SAI Life Sciences Ltd

  • Divi's Laboratories Limited

  • CORONA Remedies Ltd

  • Thyrocare Technologies Limited

  • Shilpa Medicare Ltd

  • ALEMBIC PHARMACEUTICALS LIMITED

  • METROPOLIS HEALTHCARE LIMITED

  • Dr. Reddys Laboratories Limited

  • Medi Assist Healthcare Services Ltd

  • Clearing Corporation of India Limited

  • Procter & Gamble Health Limited

  • Biocon Limited

  • Jubilant Pharmova Ltd

  • Suraksha Diagnostic Ltd

  • SANOFI CONSUMER HEALTHCARE

  • Gland Pharma Limited

  • Vijaya Diagnostic Centre Limited

  • Pfizer Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Piramal Pharma Ltd

  • Vinati Organics Limited

  • Max Healthcare Institute Limited

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Miscellaneous

  • Chemicals

View More

  • Cash

  • Equity

View More

About Aditya Birla Sun Life Pharma & Healthcare Fund

Scheme Analysis

Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Aditya Birla Sun Life Mutual Fund. It was launched on 10-Jul-2019 and currently has an AUM of ₹837.41 crore. Aditya Birla Sun Life Pharma & Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund ended down ₹-0.32(-0.93%)yesterday to ₹34.18.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah .

Fund House Contact

One World Center , Tower 1, 17th Floor, Jupiter Mill Compound, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013

022-43568000
022-43568110/ 8111